LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
12.23
+0.06 (0.49%)
Sep 8, 2025, 9:35 AM - Market open
LENSAR Market Cap
LENSAR has a market cap or net worth of $145.96 million as of September 8, 2025. Its market cap has increased by 209.70% in one year.
Market Cap
145.96M
Enterprise Value
127.27M
1-Year Change
209.70%
Ranking
Category
Stock Price
$12.23
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $145.96M, an increase of 87.12%. That is a compound annual growth rate of 13.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 145.25M | 39.88% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | 77.13M | -1.12% |
| Oct 2, 2020 | 78.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |